Searched for
INDIAN PHARMACEUTICALS
Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...- Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers facing intensive audits amid quality concernsThe government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...
- Independence Day 2026: The Kolkata chemist who sold foreign medicines, backed Swadeshi and built a pharma empireIndependence Day 2026: Butto Kristo Paul & Co. started as a modest establishment focused on importing foreign medicines. Over time, it blos...
- India sets sail to add more trade muscle as it signs PTA terms with SACUIndia and the Southern African Customs Union signed terms to start trade negotiations. This move revives talks after previous rounds stalle...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
- Why is market falling today? Sensex falls over 450 points, Nifty below 24,450. 4 key factorsOn Tuesday, Indian stock markets experienced a downturn influenced by increasing oil prices and escalating tensions in the Middle East. Nev...
- India, South Africa-led SACU group may ink terms of reference for negotiating trade pact on Aug 12India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- India's Menage a Trois: Graham Act puts New Delhi's strategic autonomy to testThe new US legislative proposal aims to introduce tariffs on nations acquiring Russian energy, challenging India to balance its energy dema...
- India must build export-oriented medical devices industry, says pharma secretaryTo bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...
- Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisionsNew rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has am...
- India's big billion-dollar trade deals are done. Now comes the real testIndia has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...
- Uzbekistan invites Indian firms for mining, minerals push ahead of PM Modi's visitIn a bid to enhance economic ties, Uzbekistan is inviting Indian investments into its mining and metallurgy sectors, highlighting lucrative...
- India Inc goes on a global shopping spree with a new wishlistIndian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...
- IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...
- India, Uzbekistan could explore FTA, says Piyush Goyal; Uzbekistan invites Indian investment in mining, rare earthsIndia and Uzbekistan aim to double bilateral trade to three billion dollars within three years. Businesses are urged to increase investment...
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
- As we look to the next decade, I hope in the future we can further grow in generics as we transition into drug innovation: Aman Mehta, MD, Torrent PharmaceuticalsTorrent Pharma aims to become a top three Indian drug maker. The company is transitioning from generics to drug innovation for growth. Aman...
- ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
Load More
